25 related articles for article (PubMed ID: 38494064)
21. Bile acids serve as endogenous antagonists of the Leukemia inhibitory factor (LIF) receptor in oncogenesis.
Di Giorgio C; Morretta E; Lupia A; Bellini R; Massa C; Urbani G; Bordoni M; Marchianò S; Lachi G; Rapacciuolo P; Finamore C; Sepe V; Chiara Monti M; Moraca F; Natalizi N; Graziosi L; Distrutti E; Biagioli M; Catalanotti B; Donini A; Zampella A; Fiorucci S
Biochem Pharmacol; 2024 May; 223():116134. PubMed ID: 38494064
[TBL] [Abstract][Full Text] [Related]
22. The Pleiotropic role, functions and targeted therapies of LIF/LIFR axis in cancer: Old spectacles with new insights.
Halder S; Parte S; Kshirsagar P; Muniyan S; Nair HB; Batra SK; Seshacharyulu P
Biochim Biophys Acta Rev Cancer; 2022 Jul; 1877(4):188737. PubMed ID: 35680099
[TBL] [Abstract][Full Text] [Related]
23. Leukaemia inhibitory factor in gastric cancer: friend or foe?
Seeneevassen L; Martin OCB; Lehours P; Dubus P; Varon C
Gastric Cancer; 2022 Mar; 25(2):299-305. PubMed ID: 35106710
[TBL] [Abstract][Full Text] [Related]
24. Leukemia inhibitory factor and human embryo implantation.
Aghajanova L
Ann N Y Acad Sci; 2004 Dec; 1034():176-83. PubMed ID: 15731310
[TBL] [Abstract][Full Text] [Related]
25. Reconstitution of high affinity leukaemia inhibitory factor (LIF) receptors in haemopoietic cells transfected with the cloned human LIF receptor.
Gearing DP; VandenBos T; Beckmann MP; Thut CJ; Comeau MR; Mosley B; Ziegler SF
Ciba Found Symp; 1992; 167():245-55; discussion 255-9. PubMed ID: 1425017
[TBL] [Abstract][Full Text] [Related]
[Previous] [New Search]